You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ISOVUE-M 200 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Isovue-m 200 patents expire, and what generic alternatives are available?

Isovue-m 200 is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in ISOVUE-M 200 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Isovue-m 200

A generic version of ISOVUE-M 200 was approved as iopamidol by HAINAN POLY on February 27th, 2023.

  Try a Trial

Summary for ISOVUE-M 200
Drug patent expirations by year for ISOVUE-M 200
Recent Clinical Trials for ISOVUE-M 200

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NYU Langone HealthN/A
National Cancer Institute (NCI)N/A
M.D. Anderson Cancer CenterN/A

See all ISOVUE-M 200 clinical trials

Pharmacology for ISOVUE-M 200

US Patents and Regulatory Information for ISOVUE-M 200

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ISOVUE-M 200 iopamidol INJECTABLE;INJECTION 018735-001 Dec 31, 1985 AP1 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ISOVUE-M 200

See the table below for patents covering ISOVUE-M 200 around the world.

Country Patent Number Title Estimated Expiration
Ireland 42620 NON-IONIC X-RAY CONTRAS AGENTS ⤷  Try a Trial
United Kingdom 1472050 ⤷  Try a Trial
Yugoslavia 196683 ⤷  Try a Trial
Croatia P931221 PROCESS FOR THE PREPARATION OF BIS-(DIHYDROXYPROPYLAMIDE) 5-HIDROXY-PROPYLAMINO-2,4,6-TRIIOD-ISOPHTALIC ACID ⤷  Try a Trial
Denmark 147336 ⤷  Try a Trial
Spain 442651 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.